TITLE

Studies on Mast Cells and Histamine Release in Psoriasis: The Effect of Ranitidine

AUTHOR(S)
Petersen, Lars I.; Hansen, Ulla; Kristensen, Johannes K.; Nielsen, Henrik; Skov, Per S.; Nielsen, Hans J.
PUB. DATE
June 1998
SOURCE
Acta Dermato-Venereologica;6/1/1998, Vol. 78 Issue 3, p190
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The purpose of this study was to investigate histamine and skin mast cells in psoriasis before and during 6 months of treatment with high-dose ranitidine. Sixteen psoriasis patients, presenting a mean PASI score of 15.4, were compared with 13 age- and sex-matched healthy controls. Resting extracellular skin levels of histamine and histamine release to mast cell secretagogues, as measured by the microdialysis technique, were increased in involved psoriasis skin compared to normal skin in the controls. Plasma histamine, but not basophil histamine release, was significantly increased in the patients. Mast cells and lymphocytes were significantly increased in numbers in involved versus non-involved skin in the patients, the lymphocytes being predominantly T-lymphocytes expressing HLA-DR activation. During 6 months of ranitidine treatment, mean PASI score of 15.4 decreased to 5.8. The lymphocyte infiltration, but not mast cell numbers, was significantly reduced during treatment, and histamine release to mast cell secretagogues was normalized. These observations suggest that skin mast cells in active psoriasis are functionally hyperreactive. The biochemical findings together with the clinical effect of ranitidine indicate that histamine may be involved in the pathophysiology of psoriasis.
ACCESSION #
4318189

 

Related Articles

  • Will antiulcer drugs be used for psoriasis? Henahan, John // Drug Topics;11/20/95, Vol. 139 Issue 22, p46 

    Reports on the possibility that the antiulcer drug ranitidine may be safe and effective for treating psoriasis.

  • Systemic Mastocytosis. Deb, Arjun; Tefferi, Ayalew // New England Journal of Medicine;8/14/2003, Vol. 349 Issue 7, pe7 

    The article describes the case of a 44-year-old woman diagnosed with systemic mast-cell disease. The patient has a one-year history of neck and lower back pain and the condition worsened over the previous two months. The results of various examinations show that she has an abnormal signal in the...

  • The Differentiation and Function of Myofibroblasts is Regulated by Mast Cell Mediators. Gailit, James; Marchese, Mary J; Kew, Richard R; Gruber, Barry L // Journal of Investigative Dermatology;Nov2001, Vol. 117 Issue 5, p1113 

    Myofibroblasts are fibroblasts that express certain features of smooth muscle differentiation. Increased numbers of myofibroblasts and mast cells are frequently found together in a wide variety of settings, such as normal wound repair and scleroderma skin, which suggests that mediators produced...

  • Erratum to: Histamine release from rat mast cells induced by the metabolic activation of drugs of abuse into free radicals. Di Bello, M.; Masini, E.; Ioannides, C.; Ndisang, J.; Raspanti, S.; Bani Sacchi, T.; Mannaioni, P. // Inflammation Research;Feb2013, Vol. 62 Issue 2, p247 

    A correction to the article "Histamine Release From Rat Mast Cells Induced by the Metabolic Activation of Drugs of Abuse Into Free Radicals," published in a previous issue of "Inflammation Research," journal, is presented.

  • Histamine, mast cells and tumour cell proliferation in breast cancer: does preoperative cimetidine administration have an effect? Bowrey, P F; King, J; Magarey, C; Schwartz, P; Marr, P; Bolton, E; Morris, D L // British Journal of Cancer;1/1/2000, Vol. 82 Issue 1, p167 

    Endogenous histamine has been shown to effect growth mechanisms in experimental mammary carcinomas via H2 membrane receptors (Cricco et al, 1994). Both H1 and H2 binding sites are present in human mammary glands but only 75% malignant carcinomas express H2 receptors (Lemos et al, 1995). The...

  • Allergy drug efficacy confirmed at molecular level. Charters, Lynda; Leornardi, Andrea // Ophthalmology Times;9/1/2003, Vol. 28 Issue 17, p15 

    Discusses the efficacy of olopatadine hydrochloride ophthalmic solution in reducing the release of mast-cell-derived mediators and allergic effects in patients with allergic conjunctivitis. Correlation of mast-cell stabilizing properties; Decrease of histamine levels to produce therapeutic...

  • Mithramycin in the Treatment of Systemic Mastocytosis. Conrad, Marcel E.; Carpenter, Jr., John T.; Todd III, John N.; Murad, Tariq M. // Annals of Internal Medicine;Nov75, Vol. 83 Issue 5, p659 

    Focuses on the case of a patient with systemic mastocytosis. Description of the condition of the patient; Use of mithramycin in the treatment of mastocytosis; Effect of mithramycin on bone pain and histamine release-type symptomatology.

  • A solitary manifestation of mastocytosis in the head and neck. Mylanus, Emmanuel A. M.; Wielinga, Eize W. J.; van de Nes, Jan A. P. // European Archives of Oto-Rhino-Laryngology;May2000, Vol. 257 Issue 5, p270 

    Solitary mastocytosis in adulthood is a rare finding. Only two such lesions have been reported in the head and neck. We describe a 27-year-old woman who had a 10-year history of a forehead swelling that had fluctuated in size. Light trauma or pressure on the lesion resulted in an increase in its...

  • Effect of chronic rantidine treatment on secretion of intrinsic factor.  // British Medical Journal (Clinical Research Edition);7/24/1982, Vol. 285 Issue 6337, p264 

    Studies the secretion of intrinsic factors on ranitidine treatment. Effects on the treatment of gastric parietal cell by H [sub 2] receptor antagonists; Measurement of the secretion of the intrinsic factor in patients 31-61 years old; Suggestions in the monitoring of cobalamin stores in long...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics